InvestorsHub Logo
Post# of 216696
Next 10
Followers 40
Posts 1173
Boards Moderated 0
Alias Born 09/13/2013

Re: None

Monday, 12/11/2017 10:57:06 PM

Monday, December 11, 2017 10:57:06 PM

Post# of 216696
$DRNK Like I said before, it is all for the benefit of $DRNK shareholders. It’s like an Elon Musk strategy when he use the proceeds from Pay-Pal to fund his other companies such as Tesla, Solar City, and SpaceX.


CEO’s response to my email back in November:
https://investorshub.advfn.com/boards/m_read_msg.aspx?message_id=136334119

$DRNK Mersky mentioning the NOHO brand and the FDA clinically-studied drug on the radio broadcast. Listen from 17:25.

http://businessradiox.com/podcast/phoenixbusinessradio/zoltan-kemeny-david-mersky/





$DRNK Just 5 Months ago $DRNK news about SNNC Sibannac.

Phoenix, AZ - July 7, 2017 - InvestorsHub NewsWire - NOHO, Inc. (OTC PINK: DRNK), a Wyoming corporation (the "Company"), announced the following:

Sibannac, Inc.

NOHO, Inc.'s CEO, David Mersky, has become the Chief Executive Officer of Sibbanac, Inc. (OTC: SNNC). Mr. Mersky will remain in his role in NOHO and at this time the acquisition by SNNC of IMBUTEK HOLDINGS, CORP., will have no effect on the NOHO shareholders. "While we had originally intended to change the name of NOHO to IMBUTEK to pursue new acquisitions, we have now determined that the NOHO brand is too valuable and must stand alone, in light of recent product distribution and the new FDA registered and clinically tested medicine that is going into production. Sibbanac will change its name to IMBUTEK HOLDINGS CORP, which will allow us to expedite our original plan. Sibbanac is fully reporting and we are catching it up on its filings, which we'll have completed very quickly." The company looks forward to updating NOHO shareholders about the impact of Sibannac's recent developments. For further information, please see the latest 8-K from Sibbanac, Inc.





Last week, Sibannac SNNC 8-k December 4, 2017

Sibannac, Inc. (Filer) CIK: 0001313938 (see all company filings)

IRS No.: 330903494 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 8-K | Act: 34 | File No.: 000-55578 | Film No.: 171237780

SIC: 2834 Pharmaceutical Preparations

https://www.sec.gov/Archives/edgar/data/1313938/000168316817003225/0001683168-17-003225-index.htm




Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.